caffeine has been researched along with Age-Related Memory Disorders in 49 studies
Excerpt | Relevance | Reference |
---|---|---|
" Since caffeine (an adenosine receptor antagonist) and selective antagonists of adenosine A2A receptors modify the course of memory impairment in different amyloid-β-based experimental models of AD, we now tested the impact of caffeine on STZ-induced dementia and associated neurodegeneration in the hippocampus as well as on the expression and density of adenosine receptors." | 7.79 | Caffeine consumption prevents memory impairment, neuronal damage, and adenosine A2A receptors upregulation in the hippocampus of a rat model of sporadic dementia. ( Costa, MS; Cunha, RA; Espinosa, J; Kalinine, E; Kazlauckas, V; Nunes, F; Porciúncula, LO; Rocha, A; Schein, V; Souza, DO, 2013) |
"L-Methionine chronic administration leads to impairment of memory." | 5.48 | Caffeine Prevents Memory Impairment Induced by Hyperhomocysteinemia. ( Alzoubi, KH; Khabour, OF; Mhaidat, NM; Obaid, EA, 2018) |
"d-galactose has been considered a senescent model for age-related neurodegenerative disease." | 5.42 | Caffeine prevents d-galactose-induced cognitive deficits, oxidative stress, neuroinflammation and neurodegeneration in the adult rat brain. ( Ali, T; Kim, MO; Ullah, F; Ullah, N, 2015) |
"I have reported a case of acute memory loss and nominal aphasia in a 36-year-old woman after the use of Dexatrim Extra Strength." | 5.27 | Acute memory loss and nominal aphasia caused by phenylpropanolamine. ( Puar, HS, 1984) |
" Since caffeine (an adenosine receptor antagonist) and selective antagonists of adenosine A2A receptors modify the course of memory impairment in different amyloid-β-based experimental models of AD, we now tested the impact of caffeine on STZ-induced dementia and associated neurodegeneration in the hippocampus as well as on the expression and density of adenosine receptors." | 3.79 | Caffeine consumption prevents memory impairment, neuronal damage, and adenosine A2A receptors upregulation in the hippocampus of a rat model of sporadic dementia. ( Costa, MS; Cunha, RA; Espinosa, J; Kalinine, E; Kazlauckas, V; Nunes, F; Porciúncula, LO; Rocha, A; Schein, V; Souza, DO, 2013) |
"In this study, the effects of caffeine (CAF) and SCH58261, a selective A(2A) receptor antagonist, on memory impairment and oxidative stress generated by aging in rats were investigated." | 3.77 | Protective effect of caffeine and a selective A2A receptor antagonist on impairment of memory and oxidative stress of aged rats. ( Brandão, R; Jesse, CR; Leite, MR; Nogueira, CW; Wilhelm, EA, 2011) |
"To examine the association between caffeine intake, cognitive decline, and incident dementia in a community-based sample of subjects aged 65 years and over." | 3.74 | The neuroprotective effects of caffeine: a prospective population study (the Three City Study). ( Ancelin, ML; Barberger-Gateau, P; Carrière, I; Dartigues, JF; de Mendonca, A; Portet, F; Ritchie, K; Rouaud, O, 2007) |
"This review examines the effects of carbohydrates, delivered individually and in combination with caffeine, on a range of cognitive domains and subjective mood." | 2.58 | The Effects of Carbohydrates, in Isolation and Combined with Caffeine, on Cognitive Performance and Mood-Current Evidence and Future Directions. ( Bernard, BN; Louise, D; Louise, LC, 2018) |
"3." | 2.41 | The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities. ( Angelucci, ME; Canteras, NS; Da Cunha, C; Takahashi, RN; Wonnacott, S, 2002) |
"Caffeine is a psychostimulant substance that is mostly used to prevent fatigue, increase alertness, and ameliorate sleep loss situations." | 1.72 | Chronic caffeine consumption improves the acute sleep deprivation-induced spatial memory impairment while altering N-methyl-D-aspartate receptor subunit expression in male rats. ( Cevik, OS; Keloglan, SM; Sahin, L, 2022) |
"Methylphenidate (MPH) is a psychostimulant widely misused to increase wakefulness by drivers and students." | 1.62 | Stimulants cocktail: Methylphenidate plus caffeine impairs memory and cognition and alters mitochondrial and oxidative status. ( Barcellos, LJG; de Alcantara Barcellos, HH; Fortuna, M; Freddo, N; Koakoski, G; Maffi, VC; Mozzato, MT; Pompermaier, A; Rossato-Grando, LG; Soares, SM; Varela, ACC, 2021) |
"L-Methionine chronic administration leads to impairment of memory." | 1.48 | Caffeine Prevents Memory Impairment Induced by Hyperhomocysteinemia. ( Alzoubi, KH; Khabour, OF; Mhaidat, NM; Obaid, EA, 2018) |
"Caffeine in both treatment regimens caused hyperlocomotion only in male rats, whereas anxiety-related behavior was attenuated in both sexes by caffeine (1." | 1.43 | Caffeine exposure during rat brain development causes memory impairment in a sex selective manner that is offset by caffeine consumption throughout life. ( Ardais, AP; Borges, MF; Botton, PH; Cunha, RA; Fioreze, GT; Mioranzza, S; Nunes, F; Pagnussat, N; Porciúncula, Lde O; Rocha, AS; Sallaberry, C, 2016) |
"Caffeine treatment was able to prevent CBD (5mg/kg) effects on memory when CBD was given after the training session." | 1.42 | Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio). ( Antonioli, R; Bonan, CD; Capiotti, KM; Crippa, JA; da Silva, RS; Hallak, JE; Nazario, LR; Zuardi, AW, 2015) |
"d-galactose has been considered a senescent model for age-related neurodegenerative disease." | 1.42 | Caffeine prevents d-galactose-induced cognitive deficits, oxidative stress, neuroinflammation and neurodegeneration in the adult rat brain. ( Ali, T; Kim, MO; Ullah, F; Ullah, N, 2015) |
"Tau pathology found in Alzheimer's disease (AD) is crucial in cognitive decline." | 1.40 | Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology. ( Blum, D; Buée, L; Carrier, S; Demeyer, D; Derisbourg, M; Eddarkaoui, S; Hamdane, M; Laurent, C; Leboucher, A; Müller, CE; Schneider, M, 2014) |
"Withdrawal of caffeine however produced memory deficits and significantly increases the immobility time of rats in FST." | 1.38 | Altered brain serotonergic neurotransmission following caffeine withdrawal produces behavioral deficits in rats. ( Haider, S; Haleem, DJ; Khaliq, S; Naqvi, F; Perveen, T; Saleem, S, 2012) |
"Caffeine (1 g/l) was applied in the drinking water from 7 months onwards." | 1.38 | Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10/LTJ mice. ( Agostinho, PM; Carvalho, RA; Cunha, RA; Duarte, JM, 2012) |
" Chronic administration of caffeine in mice (intraperitoneally, 3 mg/kg/day, for 15 days, >12 h before trials) led to an A(1)-mediated enhancement of the CB(1)-dependent acute disruptive effects of THC on a short-term spatial memory task, despite inducing a reduction in cortical and hippocampal CB(1) receptor number and an attenuation of CB(1) coupling with G protein." | 1.37 | Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory. ( Assaife-Lopes, N; Brett, RR; Pratt, JA; Ribeiro, JA; Sebastião, AM; Sousa, VC, 2011) |
"It is well known that caffeine and sleep deprivation have opposing effects on learning and memory; therefore, this study was undertaken to determine the effects of chronic (4wks) caffeine treatment (0." | 1.37 | Sleep deprivation prevents stimulation-induced increases of levels of P-CREB and BDNF: protection by caffeine. ( Aleisa, AM; Alhaider, IA; Alkadhi, KA; Tran, TT, 2011) |
"I have reported a case of acute memory loss and nominal aphasia in a 36-year-old woman after the use of Dexatrim Extra Strength." | 1.27 | Acute memory loss and nominal aphasia caused by phenylpropanolamine. ( Puar, HS, 1984) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.08) | 18.7374 |
1990's | 3 (6.12) | 18.2507 |
2000's | 12 (24.49) | 29.6817 |
2010's | 28 (57.14) | 24.3611 |
2020's | 4 (8.16) | 2.80 |
Authors | Studies |
---|---|
Sang, Z | 2 |
Pan, W | 1 |
Wang, K | 2 |
Ma, Q | 1 |
Yu, L | 1 |
Yang, Y | 1 |
Bai, P | 2 |
Leng, C | 1 |
Xu, Q | 1 |
Li, X | 1 |
Tan, Z | 1 |
Liu, W | 1 |
Zhang, P | 1 |
Shi, J | 1 |
Cheng, X | 1 |
Zhang, Q | 1 |
Zheng, C | 1 |
Cheng, Y | 1 |
Yang, J | 1 |
Lu, X | 1 |
Keloglan, SM | 1 |
Sahin, L | 2 |
Cevik, OS | 1 |
Musuroglu Keloglan, S | 1 |
Kocahan, S | 1 |
Annac, E | 1 |
Tirasci, N | 1 |
Pekmezekmek, AB | 1 |
Machado, DG | 1 |
Lara, MVS | 1 |
Dobler, PB | 1 |
Almeida, RF | 1 |
Porciúncula, LO | 5 |
Freddo, N | 1 |
Soares, SM | 1 |
Fortuna, M | 1 |
Pompermaier, A | 1 |
Varela, ACC | 1 |
Maffi, VC | 1 |
Mozzato, MT | 1 |
de Alcantara Barcellos, HH | 1 |
Koakoski, G | 1 |
Barcellos, LJG | 1 |
Rossato-Grando, LG | 1 |
Cadoni, C | 1 |
Pisanu, A | 1 |
Simola, N | 1 |
Frau, L | 1 |
Porceddu, PF | 1 |
Corongiu, S | 1 |
Dessì, C | 1 |
Sil, A | 1 |
Plumitallo, A | 1 |
Wardas, J | 1 |
Di Chiara, G | 1 |
Bernard, BN | 1 |
Louise, LC | 1 |
Louise, D | 1 |
Alzoubi, KH | 1 |
Mhaidat, NM | 1 |
Obaid, EA | 1 |
Khabour, OF | 1 |
Li, Y | 1 |
Zhang, W | 1 |
Shi, R | 1 |
Sun, M | 1 |
Zhang, L | 1 |
Li, N | 1 |
Xu, Z | 1 |
Jang, YJ | 1 |
Kim, J | 1 |
Shim, J | 1 |
Kim, CY | 1 |
Jang, JH | 1 |
Lee, KW | 1 |
Lee, HJ | 1 |
Stefanello, N | 1 |
Schmatz, R | 1 |
Pereira, LB | 1 |
Rubin, MA | 1 |
da Rocha, JB | 1 |
Facco, G | 1 |
Pereira, ME | 1 |
Mazzanti, CM | 1 |
Passamonti, S | 1 |
Rodrigues, MV | 1 |
Carvalho, FB | 1 |
da Rosa, MM | 1 |
Gutierres, JM | 1 |
Cardoso, AM | 1 |
Morsch, VM | 1 |
Schetinger, MR | 1 |
Leite, MR | 3 |
Marcondes Sari, MH | 1 |
de Freitas, ML | 1 |
Oliveira, LP | 1 |
Dalmolin, L | 1 |
Brandão, R | 2 |
Zeni, G | 2 |
Laurent, C | 1 |
Eddarkaoui, S | 1 |
Derisbourg, M | 1 |
Leboucher, A | 1 |
Demeyer, D | 1 |
Carrier, S | 1 |
Schneider, M | 1 |
Hamdane, M | 1 |
Müller, CE | 3 |
Buée, L | 1 |
Blum, D | 1 |
Cechella, JL | 1 |
da Rocha, JT | 1 |
Dobrachinski, F | 1 |
Gai, BM | 1 |
Soares, FA | 1 |
Bresciani, G | 1 |
Royes, LF | 1 |
Santos, EC | 1 |
Bicca, MA | 1 |
Blum-Silva, CH | 1 |
Costa, AP | 1 |
Dos Santos, AA | 1 |
Schenkel, EP | 1 |
Farina, M | 1 |
Reginatto, FH | 1 |
de Lima, TC | 1 |
Kaster, MP | 1 |
Machado, NJ | 2 |
Silva, HB | 1 |
Nunes, A | 1 |
Ardais, AP | 2 |
Santana, M | 1 |
Baqi, Y | 1 |
Rodrigues, AL | 1 |
Chen, JF | 1 |
Tomé, ÂR | 1 |
Agostinho, P | 1 |
Canas, PM | 2 |
Cunha, RA | 7 |
Nazario, LR | 1 |
Antonioli, R | 1 |
Capiotti, KM | 1 |
Hallak, JE | 1 |
Zuardi, AW | 1 |
Crippa, JA | 1 |
Bonan, CD | 1 |
da Silva, RS | 1 |
Ullah, F | 1 |
Ali, T | 1 |
Ullah, N | 1 |
Kim, MO | 1 |
Ning, YL | 1 |
Yang, N | 1 |
Chen, X | 1 |
Zhao, ZA | 1 |
Zhang, XZ | 1 |
Chen, XY | 1 |
Li, P | 1 |
Zhao, Y | 1 |
Zhou, YG | 1 |
Rocha, AS | 1 |
Borges, MF | 1 |
Fioreze, GT | 1 |
Sallaberry, C | 1 |
Mioranzza, S | 2 |
Nunes, F | 2 |
Pagnussat, N | 1 |
Botton, PH | 2 |
Porciúncula, Lde O | 1 |
Driscoll, I | 1 |
Shumaker, SA | 1 |
Snively, BM | 1 |
Margolis, KL | 1 |
Manson, JE | 1 |
Vitolins, MZ | 1 |
Rossom, RC | 1 |
Espeland, MA | 1 |
Diekelmann, S | 1 |
Landolt, HP | 1 |
Lahl, O | 1 |
Born, J | 1 |
Wagner, U | 1 |
Soellner, DE | 1 |
Grandys, T | 1 |
Nuñez, JL | 1 |
Cognato, GP | 1 |
Agostinho, PM | 3 |
Hockemeyer, J | 1 |
Souza, DO | 3 |
Cunha, GM | 1 |
Silva, CG | 1 |
Oliveira, JM | 1 |
Oliveira, CR | 1 |
Sousa, VC | 1 |
Assaife-Lopes, N | 1 |
Ribeiro, JA | 1 |
Pratt, JA | 1 |
Brett, RR | 1 |
Sebastião, AM | 1 |
Wilhelm, EA | 1 |
Jesse, CR | 1 |
Nogueira, CW | 1 |
Alhaider, IA | 1 |
Aleisa, AM | 1 |
Tran, TT | 1 |
Alkadhi, KA | 1 |
Khaliq, S | 1 |
Haider, S | 1 |
Naqvi, F | 1 |
Perveen, T | 1 |
Saleem, S | 1 |
Haleem, DJ | 1 |
Duarte, JM | 1 |
Carvalho, RA | 1 |
Oulès, B | 1 |
Del Prete, D | 1 |
Greco, B | 1 |
Zhang, X | 1 |
Lauritzen, I | 1 |
Sevalle, J | 1 |
Moreno, S | 1 |
Paterlini-Bréchot, P | 1 |
Trebak, M | 1 |
Checler, F | 1 |
Benfenati, F | 1 |
Chami, M | 1 |
Espinosa, J | 1 |
Rocha, A | 1 |
Costa, MS | 2 |
Schein, V | 1 |
Kazlauckas, V | 1 |
Kalinine, E | 1 |
Sanday, L | 1 |
Zanin, KA | 1 |
Patti, CL | 1 |
Fernandes-Santos, L | 1 |
Oliveira, LC | 1 |
Longo, BM | 1 |
Andersen, ML | 1 |
Tufik, S | 1 |
Frussa-Filho, R | 1 |
Da Cunha, C | 3 |
Angelucci, ME | 2 |
Canteras, NS | 1 |
Wonnacott, S | 1 |
Takahashi, RN | 3 |
Hall, SS | 1 |
Boukhezra, O | 1 |
Riviello, P | 1 |
Fu, DD | 1 |
Lui, X | 1 |
Zhao, Q | 1 |
Akman, C | 1 |
Holmes, GL | 1 |
Dash, PK | 1 |
Moore, AN | 1 |
Moody, MR | 1 |
Treadwell, R | 1 |
Felix, JL | 1 |
Clifton, GL | 1 |
Prediger, RD | 1 |
Fernandes, D | 1 |
Arendash, GW | 1 |
Schleif, W | 1 |
Rezai-Zadeh, K | 1 |
Jackson, EK | 1 |
Zacharia, LC | 1 |
Cracchiolo, JR | 1 |
Shippy, D | 1 |
Tan, J | 1 |
Ritchie, K | 1 |
Carrière, I | 1 |
de Mendonca, A | 1 |
Portet, F | 1 |
Dartigues, JF | 1 |
Rouaud, O | 1 |
Barberger-Gateau, P | 1 |
Ancelin, ML | 1 |
Puar, HS | 1 |
Riedel, W | 1 |
Hogervorst, E | 1 |
Leboux, R | 1 |
Verhey, F | 1 |
van Praag, H | 1 |
Jolles, J | 1 |
Vital, MA | 1 |
Cesário, C | 1 |
Zadusky, CR | 1 |
Rosalen, PL | 1 |
Gevaerd, MS | 1 |
Silveira, R | 1 |
Goodwin, FK | 1 |
Jarvik, ME | 1 |
Gritz, ER | 1 |
Schneider, NG | 1 |
4 reviews available for caffeine and Age-Related Memory Disorders
Article | Year |
---|---|
The Effects of Carbohydrates, in Isolation and Combined with Caffeine, on Cognitive Performance and Mood-Current Evidence and Future Directions.
Topics: Academic Performance; Affect; Animals; Caffeine; Cognition; Cognition Disorders; Dietary Carbohydrat | 2018 |
Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline.
Topics: Animals; Brain; Brain Diseases; Caffeine; Central Nervous System Stimulants; Disease Models, Animal; | 2010 |
The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities.
Topics: Animals; Caffeine; Disease Models, Animal; Humans; Levodopa; Memory Disorders; Neurons; Parkinsonian | 2002 |
Drugs and memory disorders in human aging.
Topics: Adolescent; Adult; Aged; Aging; Amphetamine; Anticonvulsants; Antidepressive Agents; Arousal; Caffei | 1972 |
3 trials available for caffeine and Age-Related Memory Disorders
Article | Year |
---|---|
Relationships Between Caffeine Intake and Risk for Probable Dementia or Global Cognitive Impairment: The Women's Health Initiative Memory Study.
Topics: Aged; Caffeine; Cognition Disorders; Estrogen Replacement Therapy; Female; Humans; Incidence; Memory | 2016 |
Sleep loss produces false memories.
Topics: Adolescent; Adult; Caffeine; Female; Humans; Hydrocortisone; Learning; Male; Memory Disorders; Menta | 2008 |
Caffeine attenuates scopolamine-induced memory impairment in humans.
Topics: Adult; Blood Pressure; Caffeine; Central Nervous System Stimulants; Chewing Gum; Coffee; Cognition; | 1995 |
42 other studies available for caffeine and Age-Related Memory Disorders
Article | Year |
---|---|
Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Blood-Brain Barrier; Butyrylcholine | 2017 |
Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Biological Tr | 2019 |
Chronic caffeine consumption improves the acute sleep deprivation-induced spatial memory impairment while altering N-methyl-D-aspartate receptor subunit expression in male rats.
Topics: Animals; Caffeine; Hippocampus; Maze Learning; Memory Disorders; Rats; Rats, Wistar; Receptors, N-Me | 2022 |
Effect of caffeine on hippocampal memory and levels of gene expression in social isolation stress.
Topics: Animals; Caffeine; Gene Expression; Hippocampus; Maze Learning; Memory Disorders; Rats; Rats, Wistar | 2023 |
Caffeine prevents neurodegeneration and behavioral alterations in a mice model of agitated depression.
Topics: Animals; Behavior, Animal; Brain; Caffeine; Central Nervous System Stimulants; Depression; Gliosis; | 2020 |
Stimulants cocktail: Methylphenidate plus caffeine impairs memory and cognition and alters mitochondrial and oxidative status.
Topics: Animals; Caffeine; Central Nervous System Stimulants; Cognition; Cognitive Dysfunction; Female; Male | 2021 |
Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence.
Topics: Animals; Brain; Caffeine; Cell Body; Cell Count; Dopaminergic Neurons; Drug Interactions; Fluorescen | 2017 |
Caffeine Prevents Memory Impairment Induced by Hyperhomocysteinemia.
Topics: Animals; Antioxidants; Caffeine; Catalase; Glutathione; Glutathione Peroxidase; Hippocampus; Hyperho | 2018 |
Prenatal caffeine damaged learning and memory in rat offspring mediated by ARs/PKA/CREB/BDNF pathway.
Topics: Animals; Brain-Derived Neurotrophic Factor; Caffeine; Cyclic AMP Response Element-Binding Protein; C | 2018 |
Decaffeinated coffee prevents scopolamine-induced memory impairment in rats.
Topics: Actins; Animals; Avoidance Learning; Blotting, Western; Brain Chemistry; Caffeine; Central Nervous S | 2013 |
Effects of chlorogenic acid, caffeine, and coffee on behavioral and biochemical parameters of diabetic rats.
Topics: Acetylcholinesterase; Animals; Anxiety; Behavior, Animal; Body Weight; Caffeine; Cerebral Cortex; Ch | 2014 |
Caffeine and diphenyl diselenide improve long-term memory impaired in middle-aged rats.
Topics: Aging; Animals; Benzene Derivatives; Caffeine; CREB-Binding Protein; Dietary Supplements; Drug Evalu | 2014 |
Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology.
Topics: Alzheimer Disease; Animals; Caffeine; Disease Models, Animal; Hippocampus; Male; Memory Disorders; M | 2014 |
Caffeine suppresses exercise-enhanced long-term and location memory in middle-aged rats: Involvement of hippocampal Akt and CREB signaling.
Topics: Aging; Animals; Caffeine; Cyclic AMP Response Element-Binding Protein; Glutamic Acid; Hippocampus; M | 2014 |
Anxiolytic-like, stimulant and neuroprotective effects of Ilex paraguariensis extracts in mice.
Topics: Acetylcholinesterase; Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Brain; Caffeine; Ce | 2015 |
Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress.
Topics: Animals; Caffeine; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mood Disorders; Neurons; Recept | 2015 |
Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio).
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Animals; Avoidance Learning; B | 2015 |
Caffeine prevents d-galactose-induced cognitive deficits, oxidative stress, neuroinflammation and neurodegeneration in the adult rat brain.
Topics: Aging; Animals; Antioxidants; Brain; Caffeine; Cognition Disorders; Disease Models, Animal; Galactos | 2015 |
Chronic caffeine exposure attenuates blast-induced memory deficit in mice.
Topics: Animals; Blast Injuries; Brain Injuries, Traumatic; Caffeine; Cerebral Cortex; Hippocampus; Male; Me | 2015 |
Caffeine exposure during rat brain development causes memory impairment in a sex selective manner that is offset by caffeine consumption throughout life.
Topics: Animals; Anxiety; Brain; Brain-Derived Neurotrophic Factor; Caffeine; Central Nervous System Stimula | 2016 |
Chronic prenatal caffeine exposure impairs novel object recognition and radial arm maze behaviors in adult rats.
Topics: Animals; Caffeine; Central Nervous System Stimulants; Female; Learning Disabilities; Male; Maze Lear | 2009 |
Caffeine and an adenosine A(2A) receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life.
Topics: Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Animals, Newborn; Caffeine; Diseas | 2010 |
Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway.
Topics: Adenosine A2 Receptor Antagonists; Alzheimer Disease; Amyloid beta-Peptides; Animals; Caffeine; Cell | 2009 |
Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.
Topics: Adenosine A1 Receptor Antagonists; Animals; Caffeine; Chronic Disease; Dronabinol; Hippocampus; Male | 2011 |
Protective effect of caffeine and a selective A2A receptor antagonist on impairment of memory and oxidative stress of aged rats.
Topics: Adenosine A2 Receptor Antagonists; Aging; Animals; Ascorbic Acid; Brain; Caffeine; Male; Memory; Mem | 2011 |
Sleep deprivation prevents stimulation-induced increases of levels of P-CREB and BDNF: protection by caffeine.
Topics: Animals; Brain; Brain-Derived Neurotrophic Factor; Caffeine; Cyclic AMP Response Element-Binding Pro | 2011 |
Altered brain serotonergic neurotransmission following caffeine withdrawal produces behavioral deficits in rats.
Topics: Animals; Brain; Caffeine; Depression; Disease Models, Animal; Humans; Hydroxyindoleacetic Acid; Immo | 2012 |
Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10/LTJ mice.
Topics: Animals; Blotting, Western; Caffeine; Diabetes Mellitus, Experimental; Hippocampus; Immunohistochemi | 2012 |
Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.
Topics: Alzheimer Disease; Aminophenols; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Prec | 2012 |
Caffeine consumption prevents memory impairment, neuronal damage, and adenosine A2A receptors upregulation in the hippocampus of a rat model of sporadic dementia.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Caffeine; Dementia; Disease Models, Animal; Hippoc | 2013 |
Role of state-dependent learning in the cognitive effects of caffeine in mice.
Topics: Analysis of Variance; Animals; Caffeine; Central Nervous System Stimulants; Cognition; Inhibition, P | 2013 |
The quest for a smart pill.
Topics: Alzheimer Disease; Animals; Behavior, Animal; Benzhydryl Compounds; Caffeine; Central Nervous System | 2003 |
Effect of the postictal state on visual-spatial memory in immature rats.
Topics: Animals; Animals, Newborn; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Convulsant | 2003 |
Post-trauma administration of caffeine plus ethanol reduces contusion volume and improves working memory in rats.
Topics: Animals; Brain Injuries; Caffeine; Cerebral Infarction; Disease Models, Animal; Drug Administration | 2004 |
Blockade of adenosine A2A receptors reverses short-term social memory impairments in spontaneously hypertensive rats.
Topics: Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Caffeine; Discrimination Learning; | 2005 |
Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
Topics: Adenosine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; | 2006 |
The neuroprotective effects of caffeine: a prospective population study (the Three City Study).
Topics: Aged; Aged, 80 and over; Agnosia; AIDS Arteritis, Central Nervous System; Amyloid beta-Peptides; Caf | 2007 |
Caffeine prevents age-associated recognition memory decline and changes brain-derived neurotrophic factor and tirosine kinase receptor (TrkB) content in mice.
Topics: Age Factors; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Caffeine; Central Nervous | 2008 |
Acute memory loss and nominal aphasia caused by phenylpropanolamine.
Topics: Acute Disease; Adult; Anomia; Aphasia; Appetite Depressants; Caffeine; Drug Combinations; Female; Hu | 1984 |
The effect of caffeine in animal models of learning and memory.
Topics: Analysis of Variance; Animals; Avoidance Learning; Caffeine; Central Nervous System Stimulants; Dise | 1999 |
Caffeine reverses the memory disruption induced by intra-nigral MPTP-injection in rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Avoidance Learning; Caffeine; Central Nervous | 2001 |
From the Alcohol, Drug Abuse, and Mental Health Administration.
Topics: Brain; Caffeine; Cocaine; Diazepam; Drug Synergism; Ethanol; Fetus; Humans; Memory; Memory Disorders | 1991 |